Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLACARD
NCT07630987Not yet recruiting
- Sponsor
- UCLouvain
- Start
- May 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by UCLouvain. Primary endpoint: Procoagulant platelet formation at 32 months. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07630987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07630987.